Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Increasing evidence has shown P2Y12 inhibitor monotherapy is a feasible alternative treatment for patients after percutaneous coronary intervention (PCI) with stent implantation in the modern era. However, patients with diabetes mellitus (DM) have a higher risk of ischemic events and more complex co...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wen-Han, Chang, Yong-Chieh, Lin, Yi-Hsiung, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Chu, Chih-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099862/
https://www.ncbi.nlm.nih.gov/pubmed/35562942
http://dx.doi.org/10.3390/ijms23094549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099862/
https://www.ncbi.nlm.nih.gov/pubmed/35562942
http://dx.doi.org/10.3390/ijms23094549

Ejemplares similares